Why is NTLA Down Today?
About Intellia Therapeutics, Inc
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering speci...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector: -3.3%
Market Comparison
Quick Trade Ideas
Options strategies to consider for NTLA's -8% move
No Options Available
NTLA doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get NTLA Alerts
We'll notify you when NTLA's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
NTLA has moved more than 3.0% down on 60 occasions in the past year.
Frequently Asked Questions
Why is NTLA stock down today?
This appears to be a sector-wide move. The IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector is down 3.3% on average.
Is NTLA stock a buy or sell right now?
Based on current analysis, NTLA shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the NTLA stock price target?
NTLA is currently trading at $11.15. Based on today's momentum, the expected short-term range is $10.82 - $11.37. See long-term price prediction →
Will NTLA stock continue falling?
Our analysis shows a 45% probability that NTLA's move continues in the next 1-3 days. Key level to watch: $10.59 (support).
Is NTLA stock oversold or overbought?
NTLA's RSI (Relative Strength Index) is currently at 44.6. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for NTLA stock?
NTLA's 10-day momentum indicator is at -1.11. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is NTLA outperforming or underperforming the market?
NTLA (-7.93%) is currently significantly underperforming the market (-7.6% vs SPY). Today, the S&P 500 (SPY) is down -0.37%, and Nasdaq (QQQ) is down -0.68%.
What does MACD indicate for NTLA?
NTLA's MACD (-0.11) is currently below the signal line (-0.04), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 12.6) is weak.
Is NTLA in an uptrend or downtrend?
Based on moving average analysis, NTLA is in a bearish trend. The price ($11.15) is trading below both the 20-day SMA ($11.79) and 50-day SMA ($12.05). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis